Back

Immunomodulatory effect of first-in-human PeriCord cardiac bioimplant: preliminary data of the PERISCOPE clinical trial

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Coronary artery disease - Treatment Nonpharmacological Treatment ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Marta Monguio-Tortajada

Health Science Research Institute Germans Trias i Pujol, Badalona (Spain)

4 More presentations in this session

Presentation thumbnail
Factors associated with early catheterization in patients randomized to the conservative strategy in the ISCHEMIA Trial
Doctor R. Pracon (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Impact of high intensity interval training on coronary atheromatous plaques evaluated by IVUS - a randomized trial
Mrs E. Vesterbekkmo (Trondheim, NO)
Abstract Slides
Presentation thumbnail
Effect of supervised high-intensity interval training on haemostasis in patients with coronary artery disease: a randomised controlled trial
Doctor J. Kristiansen (Aarhus N, DK)
Abstract Slides
Presentation thumbnail
Coronary sinus reducer device for the treatment of refractory angina therapy. A multicentric initial experience.
Doctor C. Brizido (Carnaxide, PT)
Abstract Slides

Access the full session

Session thumbnail
Coronary artery disease - Treatment

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources